RYTM NASDAQ
Rhythm Pharmaceuticals, Inc.
1W: +2.2%
1M: -6.5%
3M: -13.5%
YTD: -12.2%
1Y: -16.6%
3Y: +319.0%
5Y: +738.8%
$92.18
+2.71 (+3.03%)
Weekly Expected Move ±4.1%
$82
$86
$89
$93
$97
Credit Risk of going bust: lower than 94% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down more than 99.9%), Rhythm Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $3.7M against a stock market value of $6.35B.
Distance to default 17.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 46.1%; Altman Z'' -8.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down more than 99.9%), Rhythm Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $3.7M against a stock market value of $6.35B.
Distance to default 17.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 46.1%; Altman Z'' -8.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-06-16
Earliest Filing
2024-04-16
Latest Filing
investor: 2
partner: 1
Counterparties (Filed by RYTM)
3 relationshipsCompanies named in RYTM's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | — | investor | Investor in the issuance of Series A Convertible Preferred Stock | 2024-04-16 | View |
| LG Chem, Ltd. | — | partner | License and Share Issuance Agreement for LB54640 rights and Phase 2 study sponsorship | 2024-01-04 | View |
| HealthCare Royalty Management, LLC | — | investor | Entities managed by this LLC entered into a Revenue Interest Financing Agreement with Rhythm Pharmaceuticals to provide | 2022-06-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-04 | Earnings Release; Regulation FD; Other Events; Exhibits | View | |
| 2026-06-25 | Shareholder Vote | View | |
| 2026-06-15 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-05 | Earnings Release; Exhibits | View | |
| 2026-04-03 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-03-26 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-20 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-16 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-03-02 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-09 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2025-12-19 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-11 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-07 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-11 | Other Events; Financial Statements and Exhibits | View | |
| 2025-07-09 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-26 | Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde | View | |
| 2025-05-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR